Suchergebnisse - "Held, Gerhard"

PubPharm (167)

51

A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL

enthalten in: Leukemia | 2020

von Staiger, A. | Altenbuchinger, M. | Ziepert, M. | +32

52

Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma : Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group

enthalten in: eJHaem | 2020

von Hohloch, K. | Ziepert, M. | Truemper, L. | +5

53

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

54

Diffuses großzelliges B-Zell-Lymphom: Primär- und Rezidivtherapie

enthalten in: Der Onkologe | 2019

von Held, G. | Glaß, B.

55

Diffuses großzelliges B-Zell-Lymphom: Primär- und Rezidivtherapie

enthalten in: Der Onkologe | 2019

von Held, G. | Glaß, B.

56

Diffuses großzelliges B-Zell-Lymphom: Primär- und Rezidivtherapie

enthalten in: Der Onkologe | 2019

von Held, G. | Glaß, B.

57

Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma : efficacy of lymphoma-directed conditioning against advanced disease

enthalten in: Bone marrow transplantation | 2019

von Wulf, G. | Hasenkamp, J. | Jung, W. | +8

58

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

enthalten in: Blood | 2019

von Schlenk, R. | Weber, D. | Fiedler, W. | +36

59

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: The lancet | 19 December 2019

von Pöschel, V. | Held, G. | Ziepert, M. | +41

60

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas : a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

enthalten in: British journal of haematology | 2018

von Avivi, I. | Arcaini, L. | Ferretti, V. | +27